CIK 0001395937 · Large accelerated filer
Syndax Pharmaceuticals Inc
Sign in to watch- Ticker
- SNDX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 320162505
- Phone
- 781-419-1400
- Business address
- 730 THIRD AVENUE, 9TH FLOOR, NEW YORK, NY, 10017
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $113,716
- in 1 filing, $114K under 10b5-1 plans
Net −$113,716. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 25 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-11-04 | Metzger Michael A President and COO | Sale | −100,000 | $20.31 | $2.0M | 17,659 |
| 2020-11-04 | Metzger Michael A President and COO | Option exercise · Stock Options (Right to buy) | −100,000 | 0 | ||
| 2020-07-31 | Meyers Michael L. SVP, Chief Medical Officer | Other acquisition | +2,665 | $7.97 | $21K | 13,395 |
| 2020-07-06 | Meyers Michael L. SVP, Chief Medical Officer | Grant or award | +3,500 | 10,730 | ||
| 2020-02-12 | Metzger Michael A President and COO | Grant or award | +15,000 | 17,659 | ||
| 2020-02-12 | Metzger Michael A President and COO | Grant or award · Stock Option (Right to Buy) | +140,000 | 140,000 | ||
| 2020-02-12 | Shea Richard P Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +43,200 | 43,200 | ||
| 2020-02-12 | Meyers Michael L. SVP, Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +50,825 | 50,825 | ||
| 2020-02-12 | Morrison Briggs Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +194,000 | 194,000 | ||
| 2020-02-12 | Ordentlich Peter Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2020-02-12 | Egros Fabrice Director | Grant or award · Stock Option (Right to Buy) | +24,000 | 24,000 | ||
| 2020-02-12 | Jarrett Jennifer Director | Grant or award · Stock Option (Right to Buy) | +24,000 | 24,000 | ||
| 2020-02-12 | Katkin Keith Director | Grant or award · Stock Option (Right to Buy) | +24,000 | 24,000 | ||
| 2020-02-12 | Legault Pierre Director | Grant or award · Stock Option (Right to Buy) | +24,000 | 24,000 | ||
| 2020-02-12 | Meury William Director | Grant or award · Stock Option (Right to Buy) | +24,000 | 24,000 | ||
| 2020-02-12 | Podlesak Dennis Director | Grant or award · Stock Option (Right to Buy) | +44,000 | 44,000 | ||
| 2020-02-04 | Morrison Briggs Chief Executive Officer | Purchase | +12,500 | $8.00 | $100K | 43,900 |
| 2020-01-31 | Shea Richard P Chief Financial Officer | Other acquisition | +1,505 | $7.97 | $12K | 7,121 |
| 2019-10-10 | Morrison Briggs Chief Executive Officer | Purchase | +11,000 | $5.40 | $59K | 31,400 |
| 2019-07-31 | Shea Richard P Chief Financial Officer | Other acquisition | +1,401 | $4.89 | $7K | 5,616 |
Page 22 of 25 · 500 trades